Sign In
Free Newsletter
Exclusive: Biomedical-focused Strategic Innovation Center coming to Camden (updated)
On the heels of last week's SIC announcement with Nokia in New Brunswick, NJBIZ has learned the administration's next hub is set for South Jersey with Coriell Institute for Medical Research as its collaborator.
BioNJ celebrates life sciences industry, honors innovators
The largest life sciences association in the state recognized those driving discovery during its 32nd annual dinner meeting and innovation celebration in East Brunswick.
OPINION: Let us make some deals
As the “medicine chest of the world,” New Jersey has brought new life-altering therapies and cures to patients for decades.
GenScript Biotech sets up shop Down Under
With the new operations site and logistics center in Sydney, “Australian researchers and biotech companies will no longer need to navigate the complexities of permit applications, customs clearance, and tax payments, streamlining the procurement process, and allowing them to focus on advancing their groundbreaking research and innovation,” the company said.
Murphy-led economic mission continues in Canada with Jersey jobs, new partnerships
The delegation continues to foster cross-border collaboration, including with new jobs coming to West Caldwell and several partnerships, including with NJIT, Stevens Institute of Technology and BioNJ.
Lincoln Equities Group inks 205K square feet in H1 leasing activity
Leasing activity in the first half of the year saw particular activity from life sciences and manufacturing users looking for strategic office locations.
Cellares’ Bridgewater Smart Factory marks major milestone
The facility aims to innovate clinical and commercial-scale therapy manufacturing through integrated, advanced end-to-end, walk-away automation technologies.
BioNJ, Tech Council Ventures collaborate to lift emerging companies
The partners aim to create robust opportunities for early-stage companies to thrive and expand here in New Jersey.
Tevogen Bio providing new hope for COVID patients
2024 has been an active year for Warren-based Tevogen Bio, a clinical-stage specialty immunotherapy company that is using innovation to develop affordable personalized treatments for large patient populations.
‘New Jersey continues to lead the way in life sciences innovation’
One glance around the state – from BioNJ's annual BioPartnering Conference to a report highlighting the thriving life sciences ecosystem to a study quantifying the economic impacts of the NJ Bioscience Center Incubator – shows proof of the continued momentum of the sector.
NJ’s life sciences sector ‘at the forefront of innovation’
A new report from Choose NJ, JLL, BioNJ and NJEDA highlights the local region's 'premier' ecosystem, grounded by market access, real estate options and world-class talent.
BioNJ unveils BioPartnering Conference lineup, details
More than 90 companies will present new innovations and technologies at the annual event, which moves to Liberty Science Center this year.
